Epiomic Epidemiology Report: Wilson’s Disease Forecast In 28 Major Markets 2018-2028 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 19, 2018--The “Epiomic Epidemiology Series: Wilson’s Disease Forecast In 28 Major Markets 2018-2028” report has been added to ResearchAndMarkets.com’s offering.
Wilson’s disease, also known as progressive lenticular degeneration, is a genetic disorder inherited in an autosomal recessive manner. It is caused by mutations in a gene coding for a copper-transporting protein with a key role in copper metabolism. Reduced activity of the protein leads to copper accumulation in the body which results in various hepatic, osseous, neurological and psychiatric manifestations. Although the genotype-phenotype correlation is still to be elucidated, therapies that are currently available permit patients to live fairly normal lives. However, hepatic and neurological damage sustained prior to the commencement of therapy can be irreversible.
This report provides the current prevalent population for Wilson’s disease across 28 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Belgium, Norway, Sweden, Denmark, Finland, Austria, Switzerland, Ireland, Bulgaria, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the publisher’s analysis team, Wilson’s disease patients grouped by genetic features, various symptoms and treatments have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities of Wilson’s disease include:Hepatitis and liver cirrhosis Affective disorders Back pain and stiffness Osteoporosis and frequent bone fractures Amenorrhoea Fertility problems
Key Topics Covered:
1. List Of Tables And Figures
3. Cause Of The Disease
4. Risk Factors & Prevention
5. Diagnosis Of The Disease
6. Variation By Geography/Ethnicity
7. Disease Prognosis & Clinical Course
8. Key Comorbid Conditions / Features Associated With The Disease
9. Methodology For Quantification Of Patient Numbers
10. Top-Line Prevalence For Wilson’s Disease
11. Features Of Wilson’s Disease Patients
12. Signs And Symptoms Of Wilson’s Disease Patients
13. Hepatic Signs And Symptoms
14. Neurological Signs And Symptoms
15. Psychological Signs And Symptoms
16. Ophthalmologic Signs And Symptoms
17. Treatment Of Wilson’s Disease Patients
18. Abbreviations Used In The Report
19. Other Publisher Services & Solutions
20. Reports & Publications
21. Online Epidemiology Databases
22. Online Pharmaceutical Pricing Database
For more information about this report visit https://www.researchandmarkets.com/research/ctpf64/epiomic?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180919005659/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Central Nervous System Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/19/2018 01:10 PM/DISC: 09/19/2018 01:10 PM